Companies Cryptocurrencies
89Bio Inc
89Bio Inc
Exchange: NasdaqGM
IPO Date: 11/11/2019
CEO: Mr. Rohan Palekar
Biotechnology Healthcare 🔗
  • ETNB
  • 4.2
  • 163912976
    market cap
  • 0.02999973
If you bought

shares of 89Bio Inc (ETNB) on
You would have made
Old Price $12 Current Price $12

89bio, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in San Francisco, California and currently employs 17 full-time employees. The firm is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The Company’s lead product candidate, BIO89-100, a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is being developed for the treatment of nonalcoholic steatohepatitis (NASH). FGF21 is a metabolic hormone that regulates energy expenditure and glucose and lipid metabolism.

Address: 535 Mission St Fl 14 San Francisco CALIFORNIA 94104

Stay updated.